Galectin-10: a new structural type of prototype galectin dimer and effects on saccharide ligand binding.
暂无分享,去创建一个
Yifa Zhou | G. Tai | Jiyong Su | Chenyang Song | Yue Wang | Linlin Cui | Jin Gao | R. Wu | Yunlong Si | Guihua Tai
[1] Yifa Zhou,et al. Crystallization of Galectin-8 Linker Reveals Intricate Relationship between the N-terminal Tail and the Linker , 2016, International journal of molecular sciences.
[2] Yue Meng,et al. Human galectin-2 interacts with carbohydrates and peptides non-classically: new insight from X-ray crystallography and hemagglutination. , 2016, Acta biochimica et biophysica Sinica.
[3] Jungsoo Lee,et al. Elevated Galectin-10 Expression of IL-22 Producing T Cells in Atopic Dermatitis Patients. , 2015, The Journal of investigative dermatology.
[4] P. Agarwal,et al. Significance of Charcot Leyden crystals in liver cytology—A case report , 2015, Diagnostic cytopathology.
[5] Bin Wang,et al. Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia. , 2014, Placenta.
[6] Huiting Xue,et al. The Inhibitory Effects of a Rhamnogalacturonan Ι (RG-I) Domain from Ginseng Pectin on Galectin-3 and Its Structure-Activity Relationship* , 2013, The Journal of Biological Chemistry.
[7] D. Grimwade,et al. Acute myeloid leukaemia with mutated NPM1 presenting with extensive bone marrow necrosis and Charcot–Leyden crystals , 2013, International Journal of Hematology.
[8] L. Ellis,et al. Acute myeloid leukemia with Charcot-Leyden crystals. , 2012, Blood.
[9] T Mala,et al. CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer , 2011, Genes and Immunity.
[10] A. Ho,et al. Charcot‐Leyden crystals and bone marrow necrosis in acute myeloid leukemia , 2011, European journal of haematology.
[11] H. Hilton,et al. The mRNA level of Charcot–Leyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[12] V. Belovejdov,et al. Demonstration of Charcot-Leyden crystals in eosinophilic cystitis. , 2010, Archives of pathology & laboratory medicine.
[13] Olof Engström,et al. Protein Flexibility and Conformational Entropy in Ligand Design Targeting the Carbohydrate Recognition Domain of Galectin-3 , 2010, Journal of the American Chemical Society.
[14] E. Karlsson,et al. Structural and functional analyses of beta-glucosidase 3B from Thermotoga neapolitana: a thermostable three-domain representative of glycoside hydrolase 3. , 2010, Journal of molecular biology.
[15] L. Cardell,et al. CLC– a novel susceptibility gene for allergic rhinitis? , 2010, Allergy.
[16] V. Canzonieri,et al. Galectin‐10, Eosinophils, and Celiac Disease , 2009, Annals of the New York Academy of Sciences.
[17] G. Rabinovich,et al. Galectins: structure, function and therapeutic potential , 2008, Expert Reviews in Molecular Medicine.
[18] P. Vermeersch,et al. Acute myeloid leukemia with bone marrow necrosis and Charcot Leyden crystals , 2007, American journal of hematology.
[19] Christian Becker,et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. , 2007, Blood.
[20] G. Vasta,et al. A Galectin of Unique Domain Organization from Hemocytes of the Eastern Oyster (Crassostrea virginica) Is a Receptor for the Protistan Parasite Perkinsus marinus12 , 2007, The Journal of Immunology.
[21] P. Collins,et al. Slow diffusion of lactose out of galectin-3 crystals monitored by X-ray crystallography: possible implications for ligand-exchange protocols. , 2007, Acta crystallographica. Section D, Biological crystallography.
[22] Hans-Joachim Gabius,et al. Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. , 2004, Journal of molecular biology.
[23] A. Hoeflich,et al. Tumor galectinology: Insights into the complex network of a family of endogenous lectins , 2003, Glycoconjugate Journal.
[24] Douglas N W Cooper,et al. Galectinomics: finding themes in complexity. , 2002, Biochimica et biophysica acta.
[25] G. J. Swaminathan,et al. Charcot-Leyden Crystal Protein (Galectin-10) Is Not a Dual Function Galectin with Lysophospholipase Activity but Binds a Lysophospholipase Inhibitor in a Novel Structural Fashion* , 2002, The Journal of Biological Chemistry.
[26] J. Simon,et al. Charcot-Leyden crystals within a periapical lesion. , 2000, Journal of endodontics.
[27] Acharya,et al. Selective Recognition of Mannose by the Human Eosinophil Charcot-Leyden Crystal Protein (Galectin-10): A Crystallographic Study at 1.8 Å Resolution. , 1999, Biochemistry.
[28] K. Acharya,et al. Structural basis for the recognition of carbohydrates by human galectin-7. , 1998, Biochemistry.
[29] M. Yanagihara,et al. The ultrastructural findings of Charcot-Leyden crystals in stroma of mastocytoma. , 1998, Journal of dermatological science.
[30] K. Dyer,et al. The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes. , 1997, Genomics.
[31] Susanne Carlsson,et al. Introduction to galectins , 1997, Glycoconjugate Journal.
[32] K. Dyer,et al. Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars. , 1996, Life sciences.
[33] K. Acharya,et al. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. , 1995, Structure.
[34] S. Barondes,et al. Galectins. Structure and function of a large family of animal lectins. , 1994, The Journal of biological chemistry.
[35] S. Barondes,et al. X-ray crystal structure of the human dimeric S-Lac lectin, L-14-II, in complex with lactose at 2.9-A resolution. , 1994, The Journal of biological chemistry.
[36] D. Tenen,et al. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. , 1993, Journal of immunology.
[37] R. Eddy,et al. Localization of the human eosinophil Charcot-Leyden crystal protein (lysophospholipase) gene (CLC) to chromosome 19 and the human ribonuclease 2 (eosinophil-derived neurotoxin) and ribonuclease 3 (eosinophil cationic protein) genes (RNS2 and RNS3) to chromosome 14. , 1992, Genomics.
[38] S. Barondes,et al. Soluble lactose-binding vertebrate lectins: a growing family. , 1989, Biochemistry.
[39] K. Mann,et al. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. , 1976, The Journal of clinical investigation.
[40] J. Porath,et al. Characterization studies on a new lectin found in seeds of Vicia ervilia , 1975, FEBS letters.
[41] P. Leyden,et al. Zur Kenntniss des Bronchial-Asthma , 1872, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[42] Gabriel A. Rabinovich,et al. Galectins as modulators of tumour progression , 2005, Nature Reviews Cancer.
[43] J. Hirabayashi,et al. Galectins: a family of animal lectins that decipher glycocodes. , 1996, Journal of biochemistry.
[44] A. Dvorak,et al. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. , 1991, The American journal of pathology.
[45] A. Dvorak,et al. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas. , 1990, Laboratory investigation; a journal of technical methods and pathology.